FindTrial
Sign In

Analysis of changes in PTX3 and T-cell subpopulation levels before and after PCI treatment in AMI patients, and their correlation with coronary microcirculation dysfunction

Analysis of changes in PTX3 and T-cell subpopulation levels before and after PCI treatment in AMI patients, and their correlation with coronary microcirculation dysfunction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108293
Enrollment
Unknown
Registered
2025-08-27
Start date
2025-08-31
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary slow flow/no-reflow phenomenon

Interventions

Slow flow/no-reflow group.:NA
Control group:NA

Sponsors

First Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Meet the diagnostic criteria for acute myocardial infarction, undergo emergency PCI treatment, and collect specimens before, during, and after the procedure for TIMI classification

Exclusion criteria

Exclusion criteria: Patients who have been ill for more than 48 hours, have severe liver and kidney dysfunction, comorbidities such as malignant tumors, or contraindications to anticoagulation

Design outcomes

Primary

MeasureTime frame
Pentraxin 3;T lymphocyte;haptoglobin;—

Secondary

MeasureTime frame
TIMI FRAME COUNT;—

Countries

China

Contacts

Public ContactChunrong Jin

First Hospital of Shanxi Medical University

jinchunrong525@sina.com+86 138 3414 8646

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026